Friday, March 20, 2020
(91outcomes.com) - The treatment-focused Gulf War Illness research program expires at the end of this fiscal year. The goal is to continue to grow this critically important treatment development research for the nearly one-third of Gulf War veterans debilitated by Gulf War Illness.
It parallels the effort in the U.S. House that just concluded, led by Rep. Gregorio Sablan (D-NMI) and Rep. Jack Bergman, LtGen, USMC (Ret.) (R-Mich.) with 108 bipartisan cosigners including the leadership and many members of the House Veterans' Affairs Committee.